pargyline has been researched along with Candidiasis in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paulsen, JL | 1 |
| Bendel, SD | 1 |
| Anderson, AC | 1 |
1 other study available for pargyline and Candidiasis
| Article | Year |
|---|---|
Crystal structures of Candida albicans dihydrofolate reductase bound to propargyl-linked antifolates reveal the flexibility of active site loop residues critical for ligand potency and selectivity.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Catalytic Domain; Crystallography, X-Ray; Drug Des | 2011 |